Allworth Financial’s Precision BioSciences DTIL Stock Holding History

Allworth Financial’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$37.9K	Hold	4,825	–	–	﹤0.01%	2848
2026 Q2	$37.9K	Buy	4,825 +56	+1%	+$394	﹤0.01%	2719
2026 Q1	$26.2K	Hold	4,769	–	–	﹤0.01%	2799
2025 Q4	$19.8K	Hold	4,769	–	–	﹤0.01%	2838
2025 Q3	$26.3K	Hold	4,769	–	–	﹤0.01%	2532
2025 Q2	$20K	Hold	4,769	–	–	﹤0.01%	2524
2025 Q1	$26.2K	Hold	4,769	–	–	﹤0.01%	1914
2024 Q4	$23.7K	Hold	4,769	–	–	﹤0.01%	1991
2024 Q3	$42.7K	Hold	4,769	–	–	﹤0.01%	1480
2024 Q2	$47.1K	Hold	4,769	–	–	﹤0.01%	1413
2024 Q1	$64.7K	Hold	4,769	–	–	﹤0.01%	1195
2023 Q4	$52.2K	Hold	4,769	–	–	﹤0.01%	1180
2023 Q3	$48.8K	Hold	4,769	–	–	﹤0.01%	1126
2023 Q2	$75.3K	Hold	4,769	–	–	﹤0.01%	990
2023 Q1	$108K	Hold	4,769	–	–	﹤0.01%	831
2022 Q4	$170K	Hold	4,769	–	–	﹤0.01%	670
2022 Q3	$186K	Hold	4,769	–	–	﹤0.01%	604
2022 Q2	$229K	Buy	+4,769	New	+$280K	﹤0.01%	534

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Allworth Financial's DTIL Position: Q3 2026 in Review

Allworth Financial held its Precision BioSciences (DTIL) position steady in Q3 2026 at 4,825 shares worth $37.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2848.

Allworth Financial first reported a position in DTIL in Q2 2022 and has held it in 18 quarters since. The position peaked at $229K in Q2 2022. 75 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.

Allworth Financial held 4,825 shares of Precision BioSciences worth $37.9K as of Q3 2026.
Allworth Financial left its Precision BioSciences share count unchanged in Q3 2026.
Precision BioSciences made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #2848 holding.
Allworth Financial first reported a position in Precision BioSciences in Q2 2022 and has held it in 18 quarters since.
Allworth Financial's Precision BioSciences position peaked at $229K in Q2 2022.
75 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.